相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mucus and Cell-Penetrating Nanoparticles Embedded in Nano-into-Micro Formulations for Pulmonary Delivery of Ivacaftor in Patients with Cystic Fibrosis
Barbara Porsio et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA
Jason B. Miller et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Cystic fibrosis: current therapeutic targets and future approaches
Misbahuddin M. Rafeeq et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
CFTR Modulator Therapy for Cystic Fibrosis
Hartmut Grasemann
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pegylated Polyaspartamide-Polylactide-Based Nanoparticles Penetrating Cystic Fibrosis Artificial Mucus
Emanuela Fabiola Craparo et al.
BIOMACROMOLECULES (2016)
Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis
Maria Moreno-Sastre et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
The Mucus Barrier to Inhaled Gene Therapy
Gregg A. Duncan et al.
MOLECULAR THERAPY (2016)
CCR 20th Anniversary Commentary: In the Beginning, There Was PS-341
Beverly A. Teicher et al.
CLINICAL CANCER RESEARCH (2015)
Nanoparticle diffusion within intestinal mucus: Three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles
Muthanna Abdulkarim et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: Formulation, characterisation and functionalisation with dornase alfa (DNase)
Jill Deacon et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Next Generation Carbon Nanoparticles for Efficient Gene Therapy
Santosh K. Misra et al.
MOLECULAR PHARMACEUTICS (2015)
Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium
Nicole Ali McNeer et al.
NATURE COMMUNICATIONS (2015)
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
Eric W. F. W. Alton et al.
LANCET RESPIRATORY MEDICINE (2015)
Developments of mucus penetrating nanoparticles
Min Liu et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Transcription factors and miRNAs that regulate fetal to adult CFTR expression change are new targets for cystic fibrosis
Victoria Viart et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Gene therapy in cystic fibrosis
David K. Armstrong et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2014)
Regulation of Cystic Fibrosis Transmembrane Conductance Regulator by MicroRNA-145,-223, and-494 Is Altered in ΔF508 Cystic Fibrosis Airway Epithelium
Irene K. Oglesby et al.
JOURNAL OF IMMUNOLOGY (2013)
Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy
Katrien Forier et al.
NANOMEDICINE (2013)
The endocytosis and intracellular fate of nanomedicines: Implication for rational design
Longfa Kou et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation
Isabelle Sermet-Gaudelus
EUROPEAN RESPIRATORY REVIEW (2013)
Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: In vitro characterization and in vivo transfection after intravenous administration to mice
Diego Delgado et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
CFTR, Mucins, and Mucus Obstruction in Cystic Fibrosis
Silvia M. Kreda et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Prevalence of obstructive airway disease by spirometric indices in non-smoker subjects with IHD and HTN
Virendra C. Patil et al.
LUNG INDIA (2012)
Hyperviscous airway periciliary and mucous liquid layers in cystic fibrosis measured by confocal fluorescence photobleaching
Nico Derichs et al.
FASEB JOURNAL (2011)
The cell biology of receptor-mediated virus entry
Joe Grove et al.
JOURNAL OF CELL BIOLOGY (2011)
Gene and cell therapy for cystic fibrosis: From bench to bedside
Massimo Conese et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
N-acetylcysteine Enhances Cystic Fibrosis Sputum Penetration and Airway Gene Transfer by Highly Compacted DNA Nanoparticles
Jung Soo Suk et al.
MOLECULAR THERAPY (2011)
Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine
Jung Soo Suk et al.
NANOMEDICINE (2011)
Obesity Adversely Affects Survival in Pancreatic Cancer Patients
Robert R. McWilliams et al.
CANCER (2010)
An International Randomized Multicenter Comparison of Nasal Potential Difference Techniques
George M. Solomon et al.
CHEST (2010)
Partial Correction of Cystic Fibrosis Defects with PLGA Nanoparticles Encapsulating Curcumin
Malgorzata S. Cartiera et al.
MOLECULAR PHARMACEUTICS (2010)
The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles
Jung Soo Suk et al.
BIOMATERIALS (2009)
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells
Malgorzata S. Cartiera et al.
BIOMATERIALS (2009)
Validation of nasal potential difference measurements in gut-corrected CF knockout mice
Uta Griesenbach et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Addressing the PEG Mucoadhesivity Paradox to Engineer Nanoparticles that Slip through the Human Mucus Barrier
Ying-Ying Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Solid lipid nanoparticles for retinal gene therapy:: Transfection and intracellular trafficking in RPE cells
A. del Pozo-Rodriguez et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Newborn screening for cystic fibrosis: A lesson in public health disparities
Lainie Friedman Ross
JOURNAL OF PEDIATRICS (2008)
Poly(D,L-lactide-co-glycolide) nanoparticle agglomerates as carriers in dry powder aerosol formulation of proteins
Laura J. Peek et al.
LANGMUIR (2008)
Reproducibility of nasal potential difference measurements in cystic fibrosis
Yasmin Yaakov et al.
CHEST (2007)
G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects
Silvia G. Bompadre et al.
JOURNAL OF GENERAL PHYSIOLOGY (2007)
Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics
Victoria J. Broughton-Head et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2007)
Mucus clearance and lung function in cystic fibrosis with hypertonic saline
SH Donaldson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties
K Yoncheva et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects
ME Egan et al.
SCIENCE (2004)
The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers
MG Qaddoumi et al.
PHARMACEUTICAL RESEARCH (2004)
Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution
MW Konstan et al.
HUMAN GENE THERAPY (2004)
Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus
NN Sanders et al.
GENE THERAPY (2002)
分享论文
